Erratum: Implications of miR-148a-3p/p35/PTEN signaling in tau hyperphosphorylation and autoregulatory feedforward of Akt/CREB in Alzheimer's disease (Molecular Therapy - Nucleic Acids (2022) 27 (256–275), (S2162253121002948), (10.1016/j.omtn.2021.11.019))

Li Zeng, Hailun Jiang, Ghulam Md Ashraf, Jianghong Liu, Linlin Wang, Kaiyue Zhao, Mimin Liu, Zhuorong Li*, Rui Liu*

*Corresponding author for this work

Research output: Contribution to journalComment/debate

Abstract

(Molecular Therapy: Nucleic Acids 27, 256–275; March 2022) In the originally published version of this article, in Figure 9C, the fluorescence image of PTEN and the merged image of PTEN with phosphorylated tau PHF-1 in the hippocampus of WT control group were inadvertently duplicated for those of the PTEN siRNA-treated APP/PS1 group. The figure has been corrected to show the actual images. These changes have no impact on the results and conclusions presented in this paper. The authors regret this error.[Formula

Original languageEnglish
Article number102059
JournalMolecular Therapy Nucleic Acids
Volume34
DOIs
Publication statusPublished - 12 Dec 2023
Externally publishedYes

Fingerprint

Dive into the research topics of 'Erratum: Implications of miR-148a-3p/p35/PTEN signaling in tau hyperphosphorylation and autoregulatory feedforward of Akt/CREB in Alzheimer's disease (Molecular Therapy - Nucleic Acids (2022) 27 (256–275), (S2162253121002948), (10.1016/j.omtn.2021.11.019))'. Together they form a unique fingerprint.

Cite this